Role of nNOS in Blood Pressure Regulation in eNOS Null Mutant Mice
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Abstract —The role of neural nitric oxide synthase (nNOS) in regulating blood pressure (BP) remains uncertain. Recently it was reported that in mice lacking functional endothelial NOS (eNOS) genes (−/−), acute administration of a nonselective NOS inhibitor, N w -nitro- l -arginine, decreased mean BP, suggesting that NO released by non-eNOS isoforms increases BP. Because the inducible NOS isoform is not constitutively expressed and when induced causes hypotension, we hypothesize that it is NO produced by nNOS that increases BP in the absence of eNOS activity. To test this hypothesis, we studied the acute effect of selective and nonselective nNOS inhibitors on BP and cerebellar NOS activity in eNOS (−/−), wild-type (+/+), and heterozygous (+/−) mice as well as in +/+ mice with renovascular hypertension. Because it is not known whether the decrease in BP caused by acute NOS inhibition in −/− mice can occur chronically, we also studied the effect of chronic NOS inhibition on both BP and cerebellar NOS activity. eNOS (−/−) mice had higher BP than +/+ or +/−mice, and acute administration of the selective nNOS inhibitor 7-nitroindazole (7-NI) decreased their mean BP from 137±13 to 124±12 mm Hg ( P <0.01). In +/+, +/−, or renovascular hypertensive +/+ mice, 7-NI caused a small but insignificant rise from 105±5 to 110±6 mm Hg, from 115±9 to 119±13 mm Hg, and from 146±6 to 150±6 mm Hg, respectively. Fifteen minutes after administration of 7-NI, cerebellar NOS activity decreased by 70%; however, this inhibitory effect was brief, since 2 hours after 7-NI administration NOS returned toward control values. Chronic oral or intraperitoneal administration of 7-NI did not inhibit cerebellar NOS activity, whereas the nonselective NOS inhibitor N G -nitro- l -arginine methyl ester (L-NAME) decreased this activity by 50%. Therefore, we studied the effect of chronic L-NAME administration (4 weeks) on BP. In −/− mice, chronic L-NAME administration decreased BP from 135±4 to 120±3 mm Hg ( P <0.05), whereas in +/+ and +/−mice, as expected, it increased BP from 109±2 to 125±3 mm Hg ( P <0.001) and from 107±6 to 119±5 mm Hg ( P <0.02), respectively. After L-NAME administration was stopped, BP returned to baseline. These results suggest that in eNOS −/− mice, NO derived from nNOS increases BP both acutely and chronically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Sakuma, I., Togashi, H., Yoshioka, M., Saito, H., Yanagida, M., Tamura, M., Kobayashi, T., Yasuda, H., Gross, S. S., & Levi, R. (1992) · Circulation Research · doi:10.1161/01.res.70.3.607 · Cited by 384
Cited by
Nitric oxide signalling in cardiovascular health and disease
Farah, C., Michel, L. Y. M., & Balligand, J.-L. (2018) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.224 · Cited by 779
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Molecular control of nitric oxide synthases in the cardiovascular system
Papapetropoulos, A. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00161-3 · Cited by 185
Kaikita, K., Fogo, A. B., Ma, L., Schoenhard, J. A., Brown, N. J., & Vaughan, D. E. (2001) · Circulation · doi:10.1161/hc3301.092803 · Cited by 161
Metadata
- Authors
- Kurihara, N., Alfie, M. E., Sigmon, D. H., Rhaleb, N.-E., Shesely, E. G., & Carretero, O. A.
- Venue
- Hypertension
- Published
- 1998-11
- Volume
- 32
- Issue
- 5
- Pages
- 856-861
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2102005477
- Cited by
- 106
- References
- 2
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.